Patent details

EP1830806 Title: SUSTAINED RELEASE FORMULATION COMPRISING A SOMATOSTATIN ANALOGUE

Basic Information

Publication number:
EP1830806
PCT Application Number:
PCT/EP/2005/013703
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP058049750
PCT Publication Number:
WO/2006/066868
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SUSTAINED RELEASE FORMULATION COMPRISING A SOMATOSTATIN ANALOGUE
French Title of Invention:
COMPOSITION À LIBÉRATION PROLONGÉE COMPRENANT UN ANALOGUE DE SOMATOSTATINE
German Title of Invention:
FORMULIERUNG MIT VERZÖGERTER FREISETZUNG, ENTHALTEND EIN SOMATOSTATINANALOG
SPC Number:

Dates

Filing date:
20/12/2005
Grant date:
03/09/2014
EP Publication Date:
03/09/2014
PCT Publication Date:
29/06/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/09/2007
EP B1 Publication Date:
03/09/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/12/2014
Expiration date:
20/12/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/12/2005
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

Name:
LAMBERT Olivier
Address:
France (FR)

Priority

Priority Number:
0428151
Priority Date:
22/12/2004
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 9/08;
Filing date Document type Number of pages